ALERT: VAlidation of an 8-item questionnaire predictive for a positive CaLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease

Not Applicable

Completed

• Conditions: Immune bowel disease; Digestive System; Irritable bowel syndrome

• Registration Number: ISRCTN66310845
• Lead Sponsor: niversity Hospital of Zurich (Switzerland)

Brief Summary

2015 protocol in http://www.ncbi.nlm.nih.gov/pubmed/25757949

Detailed Description

Not available

Study Timeline

• Study Start: 2014-11-13
• Study Completion: 2016-03-31
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 242

Inclusion Criteria

1. Are aged at least 18 years (part 1, 2)
2. Are referred to their gastroenterologist for any endoscopic examination (part 1)
3. Visit their GP because of on-going unspecific gastrointestinal symptoms (abdominal pain, bloating, stool irregularities, diarrhea) for at least two weeks (part 2)
4. Underwent no earlier diagnostic procedures (endoscopy) for the current episode (part 2)

Exclusion Criteria

1. Are younger than 18 years (part 1, 2)
2. Have known further /other abdominal pathologies as e.g. cancer (part 1, 2)
3. Had previous abdominal surgeries (part 2)
4. Have been treated with steroids (topical and/or oral) and/or aminosalicylates within 30 days prior inclusion into this study (part 2)
5. Underwent endoscopic examination within 3 years prior screening (part 2)

Study & Design

• Study Type: Observational
• Study Design: Not specified